LDH release was not significantly changed in response to nintedanib, however at the highest concentration (10 μM) showed a small trend for elevated LDH release (Fig. 5 b).
← all excerpts
Prolonged Scar-in-a-Jar: an in vitro screening tool for anti-fibrotic therapies using biomarkers of extracellular matrix synthesis.
1
—
—